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The articles in this monograph focus on the
mechanisms whereby ambient particulate
matter (PM) and co-pollutants deposited in
the respiratory tract cause cardiovascular and
systemic effects, especially in persons with
preexisting conditions such as allergic hyper-
responsiveness and pulmonary, cardiac, and
vascular diseases. During the past few years, it
has become clear that inhaled pollutants cause
adverse effects outside the respiratory tract
and that these effects may in some cases be
more important than respiratory effects.
Investigators pursuing traditional approaches
to understanding mechanisms of air pollution
effects need to be brought together with those
outside that community who have expertise
in pathogenetic mechanisms by which
deposited air pollutants might affect nonres-
piratory organs. To this end, a workshop was
held and papers were developed from a broad
range of scientists having specialized expertise
in allergic and cardiovascular physiology. The
overall goal of this monograph is to bench-
mark current thinking and enhance progress
toward identifying and understanding the
mechanisms by which nonrespiratory health
effects occur and, by extension, to facilitate
the appropriate management of relationships
between air quality and health. This mono-
graph contains a compilation of multidiscipli-
nary research that forms a framework for
generating and testing plausible new research
hypotheses. Not only will this information
stimulate the thinking of researchers, but it
will also provide an improved foundation for
funding agencies and advisory groups to frame
research strategies, programs, and priorities.
Epidemiologic studies continue to conﬁrm
links between inhaled materials and nonrespi-
ratory effects. The associations between
adverse health outcomes and inhalation of air-
borne particles and co-pollutants are summa-
rized by Dockery (1). He notes that although
the relative risks for effects of particles are
greater for respiratory than for cardiovascular
deaths, the actual numbers of deaths are
greater for cardiovascular than for respiratory
causes. Increased air pollution can decrease
heart rate variability as well as increase cardiac
arrthythmias, especially in the elderly (1). The
effects can occur quickly. Dockery found an
increased risk of myocardial infarction 1–2 hr
as well as 1–2 days following elevations in
particulate matter with a mass median
aerodynamic diameter less than 2.5 µm
(PM2.5). These results are separable and addi-
tive, suggesting that particles affect cardiovas-
cular function by more than one mechanism.
Goldberg et al. (2) show that daily mortality
increases linearly as concentrations of particles
increase for individuals who had acute lower
respiratory diseases, chronic coronary artery
disease (especially the elderly), and congestive
heart failure. 
A critical analysis of selected epidemiologic
evidence linking inhalation of airborne parti-
cles and co-pollutants to cardiovascular disease
is presented by Morris (3). He points out that
classifying disease too broadly may reduce the
magnitude of the adverse health effects of
inhaled particles and that estimates of both
the magnitude and time of these effects are
very susceptible to the model employed. Both
Goldberg et al. (2) and Morris (3) note that
the inclusion of co-pollutants in models gen-
erally reduces the apparent effects of parti-
cles—an important but not surprising result.
Gwynn and Thurston (4) report that, for
multiple reasons, the socially disadvantaged
and minorities have a higher relative risk for
the adverse effects of air pollution. Walker et
al. (5) note that air pollutants can cause nose
and eye irritation, headache, and difﬁculty in
concentration. They suggest that these effects
may be widespread and could have a large eco-
nomic impact. Clearly, more research is
needed on these quality of life issues and the
impact on human health and productivity. 
Laboratory and clinical studies further
demonstrate that inhaled pollutants deposited
in the respiratory tract can cause significant
cardiovascular and systemic responses. Yeates
et al. (6) show that histamine, a mediator
released during allergen and ozone challenges
to the bronchial or alveolar regions of the
lungs, can cause decreases in blood pressure
and deterioration of blood gases. They also
demonstrate that even as little as microgram
quantities of ragweed allergen deposited in the
bronchi or alveoli of ragweed-sensitized dogs
can precipitate anaphylactic reactions, leading
to profound decreases in heart rate and blood
pressure. Watkinson et al. (7) demonstrate
that exposure of rats to a variety of inhaled
pollutants can result in signiﬁcant decreases in
heart rate and core temperature, along with
secondary decreases in related parameters such
as cardiac output, blood pressure, and ventila-
tion. They suggest that these responses may be
mediated via either humoral or neural path-
ways. Although the time courses of the
observed responses are consistent with epi-
demiologic findings of pollution-induced
increases in mortality in humans, the rele-
vance of these responses and their mechanisms
to humans has yet to be established. 
Donaldson et al. (8) present a paradigm
whereby ultrafine particles, especially those
containing transition metals, may give rise to
oxidative stress and through low density
lipoprotein oxidation destabilize atheromatous
plaques, which leads to an ischemic event.
Alternatively, particle-induced activation of
nuclear factor kappa B and the subsequent
release of cytokines affect the liver to increase
coagulation and thus gives rise to an ischemic
event. They present sufﬁcient evidence to sup-
port these hypotheses and to warrant further
research on each of the steps involved. A
framework for assessing the cardiovascular
consequences of inhaled pollutants in humans
is proposed by Frampton (9), and approaches
to analyzing the electrocardiogram for changes
in autonomic and myocardial functions are
proposed by Zareba et al. (10). 
In our attempt to understand how inhaled
materials cause responses outside the respira-
tory tract, it is becoming clear that some
materials deposited on respiratory tract epithe-
lia can be transported directly to other tissues
and organs. The transport of gases, molecules,
allergens, and particles across the bronchial
and alveolar epithelia may result directly in
systemic effects in the heart and other organs.
Higenbottam et al. (11) report that inhaled
nitric oxide (NO) has a remarkably rapid
uptake in the lungs and can increase the mis-
match of ventilation and perfusion (V/Q).
Conversely, however, they propose that
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delivery of NO in bolus form may result in a
therapeutic decrease in pulmonary artery pres-
sure while limiting V/Q mismatch. Wagner
and Foster (12) report that relatively low mol-
ecular weight 99mtechnetium–diethylenetri-
amine pentaacetate (99mTc–DTPA) (364 Da)
deposited in the bronchi is removed via both
the bronchial circulation and mucociliary
clearance, with an average retention time of
about 10 min. They propose that the rates of
both of these clearance mechanisms depend
on bronchial blood ﬂow. Takenaka et al. (13)
show that ultraﬁne silver particles deposited in
the lungs at relatively low particle concentra-
tions are cleared more rapidly than when
instilled as agglomerates. The agglomerates
were phagocytosed primarily by macrophages,
whereas they propose that the more rapid
clearance of the ultraﬁne particles was due to
transport of both solubilized and particulate
silver into the capillaries. It is not yet clear
what portion of the silver found in the liver,
kidney, and heart was translocated in particu-
late or solubilized form. Despite our limited
understanding of the kinetics, this work sug-
gests the plausibility of inhaled ultraﬁne parti-
cles giving rise to systemic responses by direct
transport. Mattoli (14) demonstrates that
allergens are transported across epithelia via
intra- and intercellular mechanisms, with the
epithelia in individuals with asthma having
increased transepithelial allergen transport and
processing characteristics at low concentra-
tions of allergens compared to nonasthmatics.
This provides additional mechanisms whereby
persons with asthma maybe at increased risk
of allergen-induced cardiovascular and
systemic reactions.
Several investigators present evidence
supporting the plausibility of the mediation of
pollutant-induced effects via neural pathways.
Exposures of animals to viruses, allergens, and
tobacco smoke cannot only activate neural
pathways but can also enhance the sensitivity
and reactivity of neural reﬂex arcs. Carr and
Undem (15) and Bonham et al. (16) give evi-
dence for such neuroplasticity by showing the
transformation of some neurons such that
they acquire chemosensitivity. Both groups
demonstrate that exposures can also increase
the sensitivity of the central processing func-
tion of neural reﬂexes, thus providing an addi-
tional mechanism for the amplification of
respiratory and cardiovascular effects. This
information suggests several potential mecha-
nisms whereby prior exposure to viruses, irri-
tants, and allergens may result in increased
risk, which is consistent with epidemiologic
ﬁndings. However, inhibitory nerves may also
play a modulatory role, as suggested by the
ﬁnding that individuals with heart–lung trans-
plant often have airway hyperresponsiveness
(11). Whereas irritation of the upper respira-
tory tract can produce reflex hypertension,
Widdicombe and Lee (17) report that irritation
of the lower respiratory tract can produce pro-
found hypotension. Lee and Widdicombe
(18) show that interactions between the
chemosensitive C ﬁbers and rapidly adapting
pulmonary receptors modulate the physiologic
responses resulting from the activation of
these ﬁbers. The C-ﬁber–initiated reﬂex path-
ways in the lungs can be sensitized by ozone
and inﬂammation, likely due to the release of
inflammatory mediators such as histamine
and prostaglandin E2 (PGE2) (18). The neural
pathways have been delineated better in ani-
mals than in humans. There is a pressing need
to delineate in humans the cardiovascular con-
sequences of irritants inhaled via the mouth
and nose separately and together and to evalu-
ate how these are effected by disease and
compromised gas exchange. 
Inhaled biogenic particles, ozone, and
airborne PM can induce changes in airway
epithelial cell function and cause inflamma-
tory cells to migrate into the airways. Wagner
et al. (19) demonstrate that in the rat, ozone
causes mucous cell metaplasia in the nasal
passages and endotoxin causes mucous cell
metaplasia in the bronchial airways, with each
toxicant enhancing the metaplastic lesions
induced by the other toxicant. Neutrophils
are implicated for part, but not all, of these
pathogenic processes. This reciprocal potenti-
ation of epithelial cell alterations by ozone
and endotoxin extends the toxicologic proﬁles
of both agents. On the basis of this informa-
tion, it is likely that both ozone and endo-
toxin may also exacerbate the respiratory
responses to other air pollutants. Harder et al.
(20) report that 2-hr exposures of healthy
persons to concentrated PM produces only
minor increases in airway neutrophils. This
suggests that either longer exposures and/or
impaired cardiopulmonary function may be
prerequisite to a more substantial inﬂamma-
tory response or that the parameters measured
are not markers for the events leading to
death. Mattoli (14) proposes that the aller-
gen-induced release of mediators from the
epithelium may have cardiovascular conse-
quences. Hastie and Peters (21) show that
human bronchial epithelial cells obtained by
brush biopsy and immersed in a medium of
pH 5 for 3 hr causes an inhibition of the
active area of ciliary activity. The recovery of
ciliary activity improved in individuals with
more severe disease. After segmental allergen
challenge, patients with mild injury were not
susceptible to an allergen-induced inhibition
of ciliary activity nor to the 3 hr of acid expo-
sure. These findings indicate the possible
induction of protective responses linked to a
heat shock protein induced by mild injury.
This protective effect appears to be lost fol-
lowing severe injury (21). These findings
highlight the importance of evaluating
disease- or pollutant-induced protective
mechanisms. 
Inhaled air pollutants can also cause
problems by impairing host defenses.
Castranova et al. (22) present data consistent
with the hypothesis that inhalation of diesel
exhaust particles increases susceptibility of the
lungs to infection by depressing the antimi-
crobial potential of alveolar macrophages.
This inhibitory effect appears to be due to the
adsorbed organic compounds rather than the
elemental carbon core of the diesel particles.
Ultraﬁne particles may be of special concern.
Beck-Speier et al. (23) demonstrate that
agglomerates of ultrafine particles cause the
release of cyclooxygenase products of
arachadonic acid metabolism from alveolar
macrophages at lower particle surface areas
than those required for the release of the
5-lipooxygenase products. The surface area of
the particles rather than the mass appears to
be the critical factor. Although release of
PGE2 may have an anti-inﬂammatory modu-
latory effect on the inflammatory reaction
induced by ultraﬁne particles, PGE2 also has
proinflammatory actions. Gilmour and col-
leagues (24) show that exposure to residual
oil fly ash may lead to an increase in pul-
monary immune response as well as an
increase in the severity of allergic lung disease.
These findings are consistent with the
increase in susceptibility of subjects with
infections and those who are allergic to
inhaled particles and allergens.
Although biomarkers were not a focus of
the articles in this monograph, their impor-
tance is noted by Dockery and several other
authors. Dr. Jaffe presented a paper in which
troponin, a biomarker for myocardial injury,
was used to illustrate the steps necessary to
validate a biomarker in terms of mechanisms,
the required specificity of biomarkers and
their potential utility in evaluating at-risk
populations (25–27). Such an assay may have
use by epidemiologists in studies of the delin-
eation of the effects of air pollution on car-
diovascular disease. The participants agreed
on the importance of identifying and devel-
oping additional biomarkers of respiratory
and cardiovascular stress and the adverse
health effects of air pollution.
The articles in this monograph are only a
sampling of the possible pathways and mech-
anisms whereby inhaled particles and co-
pollutants may cause increased morbidity and
mortality. However, these reports expand our
insight into how previously inexplicable links
might occur. This information should facili-
tate a continued iterative interaction between
epidemiology and laboratory studies. The
description of immunologic, neural, and
humoral mechanisms whereby irritants and
antigens deposited in the lungs can affect
other organs may assist epidemiologists toIntroduction
design studies targeting specific diseases,
pathogenic mechanisms, or increases in sensi-
tivity. In turn, more focused epidemiologic
studies may enable laboratory and clinical sci-
entists to direct their investigations toward
identifying key mechanisms. Further work to
identify and validate biomarkers signaling the
activation of speciﬁc mechanisms would facil-
itate both population and laboratory studies.
Together, these articles will serve the purpose
of bringing a greater knowledge of the path-
ways and mechanisms involved in the adverse
health effects of air pollution to the attention
of investigators. It is hoped that this commu-
nication will also bring a broader range of dis-
ciplines to bear on the problem of inhaled
particulate matter. 
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